Manchester Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-82
Closed -$12K 1056
2022
Q2
$12K Hold
82
﹤0.01% 466
2022
Q1
$10K Sell
82
-81
-50% -$9.88K ﹤0.01% 546
2021
Q4
$22K Hold
163
﹤0.01% 477
2021
Q3
$23K Buy
163
+151
+1,258% +$21.3K ﹤0.01% 504
2021
Q2
$1K Buy
+12
New +$1K ﹤0.01% 787
2019
Q2
Sell
-1,018
Closed -$52K 687
2019
Q1
$52K Buy
+1,018
New +$52K 0.01% 401